Letter: Ozanimod and Vedolizumab as First-Line Advanced Therapies in Ulcerative Colitis: Authors' Reply

Inflamm Bowel Dis. 2024 Dec 27:izae304. doi: 10.1093/ibd/izae304. Online ahead of print.

Authors

Aakash Desai¹, Gursimran S Kochhar¹

Affiliation

¹ Division of Gastroenterology, Hepatology & Nutrition, Allegheny Health Network, Pittsburgh, PA, USA.

PMID: 39729488
DOI: 10.1093/ibd/izae304

No abstract available

Publication types

Editorial
Comment